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Letter in Response to Above Article:
Mechanisms of T-B cell cooperation important for MOG antibody mediated
demyelination
Dusanka S. Skundric, Assistant Professor
Department of Immunology and Microbiology, Wayne State University, Detroit, MI, USA
The article by Dale et al. is significant, reporting the presence of demyelinating antibodies to MOG in
pediatric relapsing ON. [1] The role of complement activating antibodies to MOG is suggested in
pathogenesis of adult AQP4- ON. [2] In vitro experiments have indicated that MOG antibodies isolated
from pediatric ON patients perturb organization of oligodendrocyte microtubule cytoskeleton. [1]

Similarly, pronounced demyelination, damage of axonal cytoskeleton, and oligodendrocytes were
observed in experimental autoimmune encephalomyelitis (EAE) induced by immunization with MOG3555, in (B6 x SJL)F1 (H-2b/s) mice. These mice developed relapsing-remitting disease, with prominent
inflammation by CD4+ T cells followed by B220+ B cells, scattered in small perivascular infiltrates
throughout spinal cord. Production of a cytokine IL-16 by infiltrating CD4+ and B220+ T cells in CNS of
relapsing EAE mice, has been demonstrated. [3]

IL-16 is a CD4+ T cell specific chemotactic cytokine. This cytokine regulates fundamental biological
properties of CD4+ T cells, including T - B cell cooperation. [4] Cooperation between T and B cells in
regulation of autoimmune responses to MOG35-55 is critical as demonstrated by double transgenic EAE
mouse models. [5] Studies in appropriately selected animal models, which resemble immunopathology
and histopathology of anti-MOG+, AQP4- ON are needed.
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